Bank of Montreal’s Novavax NVAX Stock Holding History

Bank of Montreal’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$414K	Hold	50,900	–	–	﹤0.01%	2481
2025 Q4	$342K	Buy	+50,900	New	+$384K	﹤0.01%	2507
2024 Q3	–	Sell	-98,800	Closed	-$1.41M	–	4127
2024 Q2	$1.41M	Sell	98,800 -551,200	-85%	-$5.55M	﹤0.01%	1842
2024 Q1	$4.99M	Sell	650,000 -200,000	-24%	-$928K	﹤0.01%	1226
2023 Q4	$6.52M	Buy	+850,000	New	+$5.2M	﹤0.01%	1180
2023 Q3	–	Sell	-14,700	Closed	-$120K	–	4097
2023 Q2	$120K	Hold	14,700	–	–	﹤0.01%	3400
2023 Q1	$103K	Buy	+14,700	New	+$135K	﹤0.01%	3232
2022 Q3	–	Sell	-9,600	Closed	-$510	–	4318
2022 Q2	$510	Buy	+9,600	New	+$497K	﹤0.01%	2678
2021 Q1	–	Sell	-75,000	Closed	-$8.74M	–	5272
2020 Q4	$8.74M	Hold	75,000	–	–	0.01%	1092
2020 Q3	$8.06M	Hold	75,000	–	–	0.01%	955
2020 Q2	$7.22M	Hold	75,000	–	–	0.01%	1003
2020 Q1	$1.04M	Sell	75,000 -58,100	-44%	-$492K	﹤0.01%	1685
2019 Q4	$530K	Buy	133,100 +85,800	+181%	+$372K	﹤0.01%	2638
2019 Q3	$237K	Buy	+47,300	New	+$259K	﹤0.01%	2810
2016 Q4	–	Sell	-240	Closed	-$10K	–	4145
2016 Q3	$10K	Hold	240	–	–	﹤0.01%	3555
2016 Q2	$35K	Hold	240	–	–	﹤0.01%	3176
2016 Q1	$25K	Buy	+240	New	+$25.7K	﹤0.01%	3319

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's NVAX Position: Q1 2026 in Review

Bank of Montreal increased its Novavax (NVAX) stake by 561% in Q1 2026, buying an estimated $837K and bringing the position to 108,725 shares worth $885K. The position accounts for ﹤0.01% of the portfolio, ranked #2099.

Bank of Montreal first reported a position in NVAX in Q2 2014 and has held it in 40 quarters since. The position peaked at $32.6M in Q3 2024. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Bank of Montreal held 108,725 shares of Novavax worth $885K as of Q1 2026.
Bank of Montreal bought 92,288 Novavax shares in Q1 2026, an estimated $837K.
Novavax made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2099 holding.
Bank of Montreal first reported a position in Novavax in Q2 2014 and has held it in 40 quarters since.
Bank of Montreal's Novavax position peaked at $32.6M in Q3 2024.
258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.